Integrated Development Large growth potential through Seda’s end-to-end Pharmaceutical Development and Clinical Pharmacology services, offering a compelling value proposition for sponsors seeking streamlined, integrated CDMO support from early development through GMP manufacture and testing.

Expansion Momentum Recent facility expansions and international footprint (UK and Northern Europe) indicate capacity for larger projects and multiregional programs, presenting opportunities to win multi-site development and supply engagements.

Financial Capacity Significant investment activity and recent financing round signal stronger financial backing, enabling Seda to scale operations, accelerate project timelines, and collaborate on larger, higher-value contracts with mid-to-large biotech and pharma clients.

Leadership Experience CEO with prior AstraZeneca leadership combined with a focused, flexible biotech-centric delivery model positions Seda as a trusted partner for sponsors seeking both speed and regulatory-aligned development strategies.

Regulatory and PK Expertise Strong capabilities in regulatory CMC, DMPK, pharmacokinetic modelling, and complex parenterals offer cross-country regulatory readiness and robust data packages, appealing to sponsors aiming to de-risk timelines and optimize value inflection points.